|
|
Interactions
with Green Tea | |
Beta-Lactam
Antibiotics
In an in vitro study, epicatechin gallate, a catechin constituent of green
tea leaves, was shown to markedly lower the minimum inhibitory concentration of
beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus
(MRSA) (Shiota et al. 1999). Epicathechin gallate may restore the
effectiveness of beta-lactam antibiotics against MRSA, a major cause of
nosocomial infections in hospitals that is resistant to many antibacterial
agents including
beta-lactams. Doxorubicin
Theanine, a water-soluble amino acid from green tea leaves, has been shown to
enhance the anti-tumor activity of doxorubicin in mice. In one study, the
combination of theanine (10 mg/kg/day) with doxorubicin (2 mg/kg/day) reduced
the tumor weight to 30% of the control level and inhibited hepatic metastasis of
M5076 ovarian sarcoma (Sugiyama and Sadzuka 1999). In another study,
administration of green tea powder (1 g/kg/day po for 4 days) to Ehrlich ascites
carcinoma tumor-bearing mice enhanced the inhibitory effects of doxorubicin on
tumor growth 2.5-fold (Sadzuka et al. 1998). Coadministration of doxorubicin
with green tea increased the concentration of doxorubicin in the tumor, but not
in normal tissue. Patients undergoing chemotherapy may benefit from drinking
green tea, although clinical trials are needed to confirm these
results. Tamoxifen
In one study, a combination of green tea extract and tamoxifen significantly
enhanced induction of apoptosis by (-)-epigallocatechin gallate (EGCG) in vitro
(Suganuma et al. 1999). Drinking green tea may enhance the cancer-preventive
activity of tamoxifen, requiring smaller doses with potentially fewer side
effects.
Warfarin
Drinking large amounts of green tea may decrease the effectiveness of
warfarin. Green tea contains vitamin K (approximately 0.03 microgram of vitamin
K/100 g of brewed tea), which is known to inhibit the effects of warfarin
(Taylor and Wilt 1999). In one case study, green tea consumption was reported to
cause a fall in INR from a high of 3.79 to a low of 1.14 in a man treated with
warfarin. He had begun drinking one-half to one gallon of green tea daily during
his course of therapy with warfarin. The INR increased to 2.55 after
discontinuation of the tea. |

|
|
References |
|
Sadzuka Y, Sugiyama T, Hirota S. Modulation of cancer chemotherapy by green
tea. Clin Cancer Res. 1998;4:153-156.
Shiota S, Shimizu M, Mizushima T, Ito H, et al. Marked reduction in the
minimum inhibitory concentration (MIC) of ß-lactams in methicillin-resistant
Staphylococcus aureus produced by epicatechin gallate, an ingredient of
green tea (Camellia sinensis). Biol. Pharm. Bull.
1999;22(12):1388-1390.
Suganuma M, Okabe S, Kai Y, Sueoka N, et al. Synergistic effects of
(-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on
cancer-preventive activity in the human lung cancer cell line PC-9. Cancer
Res. 1999;59:44-47.
Sugiyama T, Sadzuka Y. Combination of theanine with doxorubicin inhibits
hepatic metastasis of M5076 ovarian sarcoma. Clin Cancer Res.
1999;5:413-416.
Taylor JR, Wilt VM. Probable antagonism of warfarin by green tea. Ann
Pharmacother. 1999;33:426-428.Tyler V. Herbs of Choice: The Therapeutic
Use of Phytomedicinals. Binghamton, NY: Pharmaceutical Products Press;
1994. |

|
Copyright © 2000 Integrative Medicine
Communications This publication contains
information relating to general principles
of medical care that should not in any event be construed as specific
instructions for individual patients. The publisher does not accept any
responsibility for the accuracy of the information or the consequences arising
from the application, use, or misuse of any of the information contained herein,
including any injury and/or damage to any person or property as a matter of
product liability, negligence, or otherwise. No warranty, expressed or implied,
is made in regard to the contents of this material. No claims or endorsements
are made for any drugs or compounds currently marketed or in investigative use.
The reader is advised to check product information (including package inserts)
for changes and new information regarding dosage, precautions, warnings,
interactions, and contraindications before administering any drug, herb, or
supplement discussed herein. | |